Clinical trial
Single Dose, Randomized, Two-period, Two-treatment, Two-sequence Crossover Relative Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets Under Fasting Condition
NCT01372345 is registered in ClinicalTrials.gov with Dr. Reddy's Laboratories Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Single Dose, Randomized, Two-period, Two-treatment, Two-sequence Crossover Relative Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets Under Fasting Condition
- Lead sponsor
- Dr. Reddy's Laboratories Limited
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 28, 2005
- Completion date
- March 31, 2005
- Enrollment
- 43 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fasting